| (2R)-N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide;hydrochloride | IC50 | 4.4 [1] |
| Marimastat | IC50 | 0.47 [1], 2.0 [2], 10000.0 [3] |
| 4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide | IC50 | 0.1 [1] |
| Methylamino-phenylalanyl-leucyl-hydroxamic acid | IC50 | 0.05 [1] |
| Methylamino-phenylalanyl-leucyl-hydroxamic acid | Ki | 1.0 [1], 2.0 [2] |
| N-(3-Methoxybenzyl)-4-Oxo-3,4-Dihydroquinazoline-2-Carboxamide | IC50 | 1100.0 [1] |
| Ilomastat | IC50 | 9.7 [1] |
| Ilomastat | Ki | 0.18 [1], 1.0 [2] |
| N-Hydroxy-4-(4-phenylsulfanylphenyl)sulfonyl-1-prop-2-ynylpiperidine-4-carboxamide | IC50 | 1.8 [1] |
| (2R,3R)-3-(Cyclopentylmethyl)-N-hydroxy-2-[[methyl(methylsulfonyl)amino]methyl]-4-oxo-4-piperidin-1-ylbutanamide | IC50 | 199.53 [1], 200.0 [2] |
| (2R)-2-[Benzyl-[4-(2-fluoroethoxy)phenyl]sulfonylamino]-N-hydroxy-3-methylbutanamide | IC50 | 2.0 [1] |
| (R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-8-phenoxyoctanehydroximic acid | Ki | 2.0 [1] |
| (R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-7-(benzyloxy)heptanehydroximic acid | Ki | 2.0 [1], 20.0 [2] |
| (R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-7-phenoxyheptanehydroximic acid | Ki | 2.0 [1] |
| Prinomastat | IC50 | 0.4 [1], 0.54 [2] |
| N-Hydroxy-N~2~-[(4-Methoxyphenyl)sulfonyl]glycinamide | Ki | 59.0 [1], 155.0 [2] |
| (2R)-2-[Benzyl-(4-methoxyphenyl)sulfonylamino]-N-hydroxy-3-methylbutanamide | Ki | 23.0 [1] |
| (R)-N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamide | IC50 | 1.6 [1] |
| 2-[(4-Chlorophenyl)methylthio]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one | IC50 | 40000.0 [1], 100000.0 [2] |
| CID 6914621 | Ki | 257.0 [1] |
| cis-2-Aminocyclohexylcarbamoylphosphonic acid | IC50 | 100000.0 [1] |
| N1,2-Dibenzyl-N3-hydroxymalonamide | Ki | 3090.3 [1], 3100.0 [2] |
| N-Hydroxy-1-(2-methoxyethyl)-4-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonylpiperidine-4-carboxamide | IC50 | 1.7 [1] |
| 4-{[1-Methyl-2,4-Dioxo-6-(3-Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2h)-Yl]methyl}benzoic Acid | IC50 | 30000.0 [1], 100000.0 [2] |
| (3R,4R)-N-Hydroxy-4-[[4-[[2-(trifluoromethyl)benzimidazol-1-yl]methyl]benzoyl]amino]oxane-3-carboxamide | Ki | 10000.0 [1] |
| 2-(Biphenyl-4-ylsulfonamido)-N-hydroxyacetamide | IC50 | 7.0 [1] |
| 2-(Biphenyl-4-ylsulfonamido)-N-hydroxyacetamide | Ki | 9.0 [1] |
| (2S,3R)-2-(Cyclopropylmethylamino)-N-hydroxy-N'-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-3-[(3-hydroxyphenyl)methyl]butanediamide | Ki | 171.0 [1] |
| N-Hydroxy-2-[(4-nitro-benzyl)-pentafluorobenzenesulfonyl-amino]-acetamide | Ki | 0.1 [1] |
| N1-Hydroxy-2-isobutyl-N3-(3-phenylpropyl)malonamide | Ki | 537.03 [1], 540.0 [2] |
| Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate | IC50 | 30000.0 [1], 100000.0 [2] |
| (8S,11R,12S)-12-N-Hydroxy-8-N-(2-morpholin-4-yl-2-oxoethyl)-2,10-dioxo-11-[[4-[2-(trifluoromethyl)phenyl]phenyl]methyl]-1-oxa-3,9-diazacyclopentadecane-8,12-dicarboxamide | Ki | 126.0 [1], 200.0 [2] |
| N-Hydroxy-2-[(4-methoxy-benzenesulfonyl)-(4-nitro-benzyl)-amino]-acetamide | Ki | 21.0 [1] |
| N-Hydroxy-2-[(4-nitro-benzyl)-(nonafluorobutane-1-sulfonyl)-amino]-acetamide | Ki | 2.4 [1] |
| 2-Benzyl-N1-hydroxy-N3-(3-phenylpropyl)malonamide | Ki | 560.0 [1], 562.34 [2] |
| Ethyl 2-benzyl-3-(hydroxyamino)-3-oxopropanoate | Ki | 52480.75 [1], 53000.0 [2] |
| Mmp-8 inhibitor i | IC50 | 4.0 [1] |
| (2R)-2-[[4-(4-Methoxyphenyl)phenyl]sulfonylamino]-2-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]acetic acid | IC50 | 1.5 [1], 1.51 [2] |
| (3S)-N-Hydroxy-4-(4-methoxyphenyl)sulfonyl-2,2-dimethyl-1,1-dioxo-1,4-thiazepane-3-carboxamide | IC50 | 2.4 [1] |
| (1S)-1-{[(4'-Methoxy-1,1'-biphenyl-4-YL)sulfonyl]amino}-2-methylpropylphosphonic acid | IC50 | 810.0 [1] |
| (1S)-1-{[(4'-Methoxy-1,1'-biphenyl-4-YL)sulfonyl]amino}-2-methylpropylphosphonic acid | Ki | 700.0 [1] |
| (1R)-1-{[(4'-Methoxy-1,1'-biphenyl-4-YL)sulfonyl]amino}-2-methylpropylphosphonic acid | IC50 | 1.4 [1] |
| (1R)-1-{[(4'-Methoxy-1,1'-biphenyl-4-YL)sulfonyl]amino}-2-methylpropylphosphonic acid | Ki | 0.6 [1] |
| N-[4-[2-(Hydroxyamino)-2-oxoethyl]oxan-4-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide | Ki | 3100.0 [1] |
| 2-[Methyl[4-(2-butynyloxy)phenylsulfonyl]amino]acetohydroximic acid | Ki | 43.0 [1], 800.0 [2] |
| (S)-N-Hydroxy-4-(4-methoxyphenylsulfonyl)-2,2-dimethyl-1,4-thiazepane-3-carboxamide | IC50 | 1.4 [1] |
| (2R)-1-N-Hydroxy-2-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-5-N-(2-phenylethyl)pentane-1,2,5-tricarboxamide | Ki | 32.0 [1] |
| (2R,3R)-3-(Cyclopentylmethyl)-2-[[dimethylsulfamoyl(methyl)amino]methyl]-N-hydroxy-4-oxo-4-piperidin-1-ylbutanamide | IC50 | 10.0 [1] |
| 2-[1-(2-Methoxyethoxycarbonyl)piperidin-4-yl]-2-[[4-(4-methylsulfanylphenyl)phenyl]sulfonylamino]acetic acid | IC50 | 1.8 [1], 1.82 [2] |
| 2-[1-(2-Methoxyethoxycarbonyl)piperidin-4-yl]-2-[[4-(4-methoxyphenyl)phenyl]sulfonylamino]acetic acid | IC50 | 3.39 [1], 3.4 [2] |
| N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)-2-benzenesulfonylamino-propionamide | Ki | 15000.0 [1] |
| (4'-Methoxy-biphenyl-4-sulfonylamino)-[1-(morpholine-4-carbonyl)-piperidin-4-yl]-acetic acid | IC50 | 3.0 [1], 3.02 [2] |
| (R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-7-hydroxyheptanehydroximic acid | Ki | 7.0 [1] |
| 3-(4-Phenoxy-benzenesulfonyl)-propane-1-thiol | IC50 | 4.0 [1] |
| N1-Hydroxy-2-phenethyl-N3-(3-phenylpropyl)malonamide | Ki | 489.78 [1], 490.0 [2] |
| (R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-8-hydroxyoctanehydroximic acid | Ki | 4.0 [1] |
| (2R)-1-N-Hydroxy-2-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-5-N-propylpentane-1,2,5-tricarboxamide | Ki | 2.0 [1] |
| (R)-3-[[[(S)-2-Phenyl-1-(N-methylcarbamoyl)ethyl]amino]carbonyl]-6-(benzyloxy)hexanehydroximic acid | Ki | 1.0 [1] |
| (2R)-5-N-Benzyl-1-N-hydroxy-2-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]pentane-1,2,5-tricarboxamide | Ki | 30.0 [1] |
| (3R)-N-Hydroxy-2-(4-methoxyphenyl)sulfonyl-1,3,4,9-tetrahydropyrido[3,4-b]indole-3-carboxamide | IC50 | 3.0 [1] |
| (3S,5R,14S)-14-(Methylcarbamoyl)-2,8-dioxo-3-(2-phenylethyl)-1,4,9-triazacyclotetradecane-5-carboxylic acid | Ki | 17.0 [1] |
| 2-Benzyl-N-hydroxy-3-morpholino-3-oxopropanamide | Ki | 50000.0 [1], 50118.72 [2] |
| (3R)-N-Hydroxy-2-(4-morpholin-4-ylphenyl)sulfonyl-1,3,4,9-tetrahydropyrido[3,4-b]indole-3-carboxamide | IC50 | 70.0 [1] |
| N1,2-Dihydroxy-N3-(3-phenylpropyl)malonamide | Ki | 2290.87 [1], 2300.0 [2] |
| N1-Benzyl-N3-hydroxy-2-phenethylmalonamide | Ki | 2290.87 [1], 2300.0 [2] |
| (3R)-2-(4-Phenoxyphenyl)sulfonyl-1,3,4,9-tetrahydropyrido[3,4-b]indole-3-carboxylic acid | IC50 | 100.0 [1] |
| (3R)-N-Hydroxy-2-(4-phenoxyphenyl)sulfonyl-1,3,4,9-tetrahydropyrido[3,4-b]indole-3-carboxamide | IC50 | 7.0 [1], 8.0 [2] |
| Ethyl 3-(hydroxyamino)-3-oxo-2-phenylpropanoate | Ki | 97723.72 [1], 98000.0 [2] |
| Ethyl 2-(hydroxycarbamoyl)-4-phenylbutanoate | Ki | 189000.0 [1], 190546.07 [2] |
| (6R)-N-Hydroxy-5-(4-methoxyphenyl)sulfonyl-1-methyl-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxamide | IC50 | 3.0 [1] |
| 2-[1-(2-Methoxyethoxycarbonyl)piperidin-4-yl]-2-[[4-(4-methoxyphenyl)phenyl]sulfonyl-methylamino]acetic acid | IC50 | 3.6 [1], 3.63 [2] |
| 2-(1-Ethoxycarbonylpiperidin-4-yl)-2-[[4-(4-methoxyphenyl)phenyl]sulfonylamino]acetic acid | IC50 | 2.69 [1], 2.7 [2] |
| 2-[[4-(4-Methoxyphenyl)phenyl]sulfonylamino]-2-(1-propan-2-yloxycarbonylpiperidin-4-yl)acetic acid | IC50 | 1.5 [1], 1.51 [2] |
| 2-(1-Methoxycarbonylpiperidin-4-yl)-2-[[4-(4-methoxyphenyl)phenyl]sulfonylamino]acetic acid | IC50 | 6.7 [1], 6.76 [2] |
| 2-[[4-(4-Methoxyphenyl)phenyl]sulfonylamino]-2-[1-(3-methylbutanoyl)piperidin-4-yl]acetic acid | IC50 | 5.25 [1], 5.3 [2] |
| 2-[1-(2-Methoxyethoxycarbonyl)piperidin-4-yl]-2-[2-methoxyethyl-[4-(4-methoxyphenyl)phenyl]sulfonylamino]acetic acid | IC50 | 2.4 [1] |
| 2-[1-(2-Methoxyethoxycarbonyl)piperidin-4-yl]-2-[(4-phenoxyphenyl)sulfonylamino]acetic acid | IC50 | 25.7 [1], 25.8 [2] |
| (2S)-2-[[4-(4-Methoxyphenyl)phenyl]sulfonylamino]-2-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]acetic acid | IC50 | 3.0 [1], 3.02 [2] |
| 2-[(4-Butoxyphenyl)sulfonylamino]-2-[1-(2-methoxyethoxycarbonyl)piperidin-4-yl]acetic acid | IC50 | 294.0 [1], 295.12 [2] |
| (6R)-5-(4-Methoxyphenyl)sulfonyl-1-methyl-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid | IC50 | 1000.0 [1], 10000.0 [2] |
| Mmp-8 inhibitor i, negative control | IC50 | 1000.0 [1] |
| 4-[(Biphenyl-4-sulfonylamino)-carboxy-methyl]-piperidine-1-carboxylic acid 2-methoxy-ethyl ester | IC50 | 44.67 [1], 44.8 [2] |
| 4-[2-[[6-Fluoro-2-[(3-methoxyphenyl)methylcarbamoyl]-4-oxo-3H-quinazolin-5-yl]oxy]ethyl]benzoic acid | IC50 | 720.0 [1] |
| N-[(1R)-1-Cyclohexyl-2-(methylamino)-2-oxoethyl]-5-[3-fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]furan-2-carboxamide | IC50 | 5000.0 [1] |
| N-[(1S)-1-Cyclohexyl-2-(methylamino)-2-oxoethyl]-5-[3-fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]furan-2-carboxamide | IC50 | 5000.0 [1] |
| 5-[3-Fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]-N-[(2S)-3-methyl-1-(methylamino)-1-oxobutan-2-yl]furan-2-carboxamide | IC50 | 5000.0 [1] |
| 5-[3-Fluoro-4-[(4-oxo-3,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)sulfanylmethyl]phenyl]-N-[(2R)-3-methyl-1-(methylamino)-1-oxobutan-2-yl]furan-2-carboxamide | IC50 | 5000.0 [1] |
| 3-[4-(Phenylthio)phenylsulfonyl]propane-1-thiol | IC50 | 36.0 [1] |
| N-Hydroxy-4-[4-[3-[(4-methoxybenzoyl)amino]propoxy]phenyl]sulfonyloxane-4-carboxamide | IC50 | 900.0 [1] |
| N-Hydroxy-4-[4-[3-[(4-methoxybenzoyl)amino]propoxy]phenyl]sulfonyloxane-4-carboxamide | Ki | 900.0 [1] |
| 3-{[4-(But-2-Yn-1-Yloxy)phenyl]sulfonyl}propane-1-Thiol | Ki | 2700.0 [1] |
| (3R,4R)-N-Hydroxy-4-[[4-[[2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]methyl]benzoyl]amino]oxane-3-carboxamide | Ki | 3058.0 [1] |
| [2-[[1-Amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl]-5-phenylpentyl]-[2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphinic acid | IC50 | 2.5 [1] |
| [2-[[1-Amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl]-5-phenylpentyl]-[2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphinic acid | Ki | 2.5 [1] |
| 2-[(3R)-2-[4-(4-Chlorophenyl)phenyl]sulfonyl-3,4-dihydro-1H-isoquinolin-3-yl]-2-oxoacetic acid | IC50 | 5.0 [1] |
| 2-[(3S)-2-[4-(4-Fluorophenyl)phenyl]sulfonyl-3,4-dihydro-1H-isoquinolin-3-yl]-2-oxoacetic acid | IC50 | 4000.0 [1] |
| 2-[(3R)-2-[4-(4-Fluorophenyl)phenyl]sulfonyl-3,4-dihydro-1H-isoquinolin-3-yl]-2-oxoacetic acid | IC50 | 20.0 [1] |
| (2R,3R)-3-(Cyclopentylmethyl)-N-hydroxy-2-[[methylsulfonyl(propan-2-yl)amino]methyl]-4-oxo-4-piperidin-1-ylbutanamide | IC50 | 100.0 [1] |
| (2R,3R)-2-[[[5-(Dimethylamino)naphthalen-1-yl]sulfonyl-methylamino]methyl]-N-hydroxy-5-methyl-3-(piperidine-1-carbonyl)hexanamide | IC50 | 10.0 [1] |
| (2R,3R)-2-[Methyl(methylsulfonyl)aminomethyl]-3-(piperidinocarbonyl)-5-methylhexanehydroximic acid | IC50 | 100.0 [1] |